Research graph
References from Targeting the γc pathway in alopecia areata: What does it add in the era of JAK inhibitors?. Local targets link to admitted publications; unresolved targets remain external evidence.
Blockade of IL-7 signaling suppresses inflammatory responses and reverses alopecia areata in C3H/HeJ mice
10.1126/sciadv.abd1866 · 2021 · External reference
Alopecia areata: from immunopathogenesis to emerging therapeutic approaches
10.3389/fimmu.2025.1681163 · 2025 · External reference
Patterns of clinical response in patients with alopecia areata treated with ritlecitinib in the Allegro clinical development programme
10.1111/jdv.20547 · 2025 · External reference
Two phase 3 trials of baricitinib for alopecia areata
10.1056/nejmoa2110343 · 2022 · External reference
Efficacy and safety of deuruxolitinib, an oral selective Janus kinase inhibitor, in adults with alopecia areata: results from the Phase 3 randomized, controlled trial (THRIVE-AA1)
10.1016/j.jaad.2024.06.097 · 2024 · External reference
Efficacy and safety of ritlecitinib in adults and adolescents with alopecia areata: a randomised, double-blind, multicentre, phase 2b-3 trial
10.1016/s0140-6736(23)00222-2 · 2023 · External reference
New insights into the regulation of T cells by gamma(c) family cytokines
10.1038/nri2580 · 2009 · External reference
Selective blockade of γc pathway ameliorates alopecia areata in a humanized murine model [e-pub ahead of print]
10.1016/j.jid.2026.05.028 · 2026 · External reference
Alopecia areata is driven by cytotoxic T lymphocytes and is reversed by JAK inhibition
10.1038/nm.3645 · 2014 · External reference
